CoChat
Sign Up
Cited by 2

The DOI matches its Crossref record.

Eps15 homology domain 1 promotes the evolution of papillary thyroid cancer by regulating endocytotic recycling of epidermal growth factor receptor

Liu, Yu, Liang, Yanan, Li, Ming, Liu, Duanyang, Tang, Jing, Yang, Weiwei, Tong, Dandan, Jin, Xiaoming·2018·Oncology Letters
DOI 10.3892/ol.2018.9200PMC PMC6126170
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/ol.2018.9200

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • EHD1 and EGFR expression levels are increased in human papillary thyroid cancer, and EHD1 protein levels are significantly associated with tumor size, lymph node metastasis, and EGFR expression.

    “EHD1 and EGFR expression levels were also reported to be increased in human papillary thyroid cancer, and levels of EHD1 protein were significantly associated with tumor size, lymph node metastasis, and EGFR expression (46).”

    From EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling (2020) · cites this paper as [46]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 31

  1. Siegel, 2017, Cancer statistics, 2017, CA Cancer J Clin, 67, 7, 10.3322/caac.21387 · DOI · Paper page
  2. Mohammed, 2014, Advanced thyroid cancers: New era of treatment, Med Oncol, 31, 49, 10.1007/s12032-014-0049-x · DOI
  3. Herbst, 2004, Review of epidermal growth factor receptor biology, Int J Radiat Oncol Biol Phys, 59, S21, 10.1016/j.ijrobp.2003.11.041 · DOI
  4. Hsu, 2017, Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: A population-based study, Acta Oncol, 56, 1175, 10.1080/0284186X.2017.1328128 · DOI
  5. Cao, 2015, Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in china, Breast Cancer Res, 17, 115, 10.1186/s13058-015-0628-6 · DOI
  6. Tanaka, 2011, Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer, Cancer Boil Ther, 11, 50, 10.4161/cbt.11.1.13877 · DOI
  7. 2010, Mallick UK and American Thyroid A: The revised American Thyroid Association management guidelines 2009 for patients with differentiated thyroid cancer: An evidence-based risk-adapted approach, Clin Oncol (R Coll Radiol), 22, 472, 10.1016/j.clon.2010.05.001 · DOI
  8. Tong, 2017, Increased Eps15 homology domain 1 and RAB11FIP3 expression regulate breast cancer progression via promoting epithelial growth factor receptor recycling, Tumour Biol, 39, 1010428317691010, 10.1177/1010428317691010 · DOI · Paper page
  9. Wang, 2017, Caveolin-1: An oxidative stress-related target for cancer prevention, Oxid Med Cell Longev, 2017, 7454031, 10.1155/2017/7454031 · DOI
  10. Nwosu, 2016, Caveolin-1 in the regulation of cell metabolism: A cancer perspective, Mol Cancer, 15, 71, 10.1186/s12943-016-0558-7 · DOI
  11. Moreno-Caceres, 2014, Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17, Cell Death Dis, 5, e1326, 10.1038/cddis.2014.294 · DOI
  12. Xu, 2014, Src/caveolin- 1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cells, Oncol Rep, 32, 318, 10.3892/or.2014.3183 · DOI
  13. Zhang, 2012, Rabs and EHDs: Alternate modes for traffic control, Biosci Rep, 32, 17, 10.1042/BSR20110009 · DOI
  14. Grant, 2008, Mechanisms of EHD/RME-1 protein function in endocytic transport, Traffic, 9, 2043, 10.1111/j.1600-0854.2008.00834.x · DOI · Paper page
  15. Butterworth, 2012, Rab11b regulates the trafficking and recycling of the epithelial sodium channel (ENaC), Am J Physiol Renal Physiol, 302, F581, 10.1152/ajprenal.00304.2011 · DOI
  16. Bhuin, 2015, Rab11 in disease progression, Int J Mol Cell Med, 4, 1
  17. Vetter, 2015, Structure of Rab11-FIP3-Rabin8 reveals simultaneous binding of FIP3 and Rabin8 effectors to Rab11, Nat Struc Mol Boil, 22, 695, 10.1038/nsmb.3065 · DOI
  18. Takahashi, 2011, Distinct roles of Rab11 and Arf6 in the regulation of Rab11-FIP3/arfophilin-1 localization in mitotic cells, Genes Cells, 16, 938, 10.1111/j.1365-2443.2011.01538.x · DOI
  19. Collins, 2012, Rab11-FIP3 is a cell cycle-regulated phosphoprotein, BMC Cell Boil, 13, 4, 10.1186/1471-2121-13-4 · DOI
  20. Iaea, 2017, Role of STARD4 in sterol transport between the endocytic recycling compartment and the plasma membrane, Mol Biol Cell, 28, 1111, 10.1091/mbc.e16-07-0499 · DOI
  21. Chung, 2014, Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants, World J Clin Oncol, 5, 806, 10.5306/wjco.v5.i5.806 · DOI
  22. Gao, 2014, Expression of TGFβ-1 and EHD1 correlated with survival of non-small cell lung cancer, Tumour Biol, 35, 9371, 10.1007/s13277-014-2164-x · DOI · Paper page
  23. Meng, 2017, Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition, Oncotarget, 8, 22433, 10.18632/oncotarget.11220 · DOI
  24. Hoop, 2012, Structural characterization of the caveolin scaffolding domain in association with cholesterol-rich membranes, Biochemistry, 51, 90, 10.1021/bi201356v · DOI
  25. Lee, 2013, Prognostic value of epidermal growth factor receptor, p53 and galectin-3 expression in papillary thyroid carcinoma, J Int Med Res, 41, 825, 10.1177/0300060513477312 · DOI
  26. Paskas, 2014, Caveolin-1 expression in papillary thyroid carcinoma: Correlation with clinicopathological parameters and BRAF mutation status, Otolaryngol Head Neck Surg, 150, 201, 10.1177/0194599813512781 · DOI
  27. Chen, 2015, Expression of the estrogen receptor α, progesterone receptor and epidermal growth factor receptor in papillary thyroid carcinoma tissues, Oncol Lett, 10, 317, 10.3892/ol.2015.3223 · DOI
  28. Tang, 2014, High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma, Int J Clin Exp Pathol, 7, 3213
  29. Gidon, 2012, A Rab11A/myosin Vb/Rab11-FIP2 complex frames two late recycling steps of langerin from the ERC to the plasma membrane, Traffic, 13, 815, 10.1111/j.1600-0854.2012.01354.x · DOI
  30. Naslavsky, 2006, Interactions between EHD proteins and Rab11-FIP2: A role for EHD3 in early endosomal transport, Mol Boil Cell, 17, 163, 10.1091/mbc.e05-05-0466 · DOI · Paper page
  31. Horgan, 2007, Rab11-FIP3 is critical for the structural integrity of the endosomal recycling compartment, Traffic, 8, 414, 10.1111/j.1600-0854.2007.00543.x · DOI

Cited by

Sorted by citations

Metadata

Authors
Liu, Y., Liang, Y., Li, M., Liu, D., Tang, J., Yang, W., Tong, D., & Jin, X.
Affiliations
  • Department of Pathology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China
  • Institute of Iodine Deficiency Disorders, Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China
Venue
Oncology Letters
Publisher
Spandidos Publications
Published
2018-07-24
ISSN
  • 1792-1074
  • 1792-1082
DOI
10.3892/ol.2018.9200
PMC
PMC6126170
Cited by
2
References
0

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review